Life Science

Racemic version of a CYP450 metabolite of arachidonic acid.

An internal standard for the quantification of (&plusmn)5(6)-EET by GC- or LC-MS.

An internal standard for the quantification of (&plusmn)5(6)-EET by GC- or LC-MS.

An internal standard for the quantification of (&plusmn)5(6)-EET by GC- or LC-MS.

(&plusmn)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE.

(&plusmn)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE.

(&plusmn)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE.

(&plusmn)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE.

(&plusmn)5-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of (&plusmn)5-HETE. (&plusmn)5-HETE lactone is an inhibitor of 5-LO from rat basophilic leukemia cells with an

(&plusmn)5-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of (&plusmn)5-HETE. (&plusmn)5-HETE lactone is an inhibitor of 5-LO from rat basophilic leukemia cells with an

(&plusmn)5-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of (&plusmn)5-HETE. (&plusmn)5-HETE lactone is an inhibitor of 5-LO from rat basophilic leukemia cells with an

(&plusmn)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The methyl ester of (&plusmn)5-HETE has no distinguishing biological activity.